JP2017505624A5 - - Google Patents

Download PDF

Info

Publication number
JP2017505624A5
JP2017505624A5 JP2016549436A JP2016549436A JP2017505624A5 JP 2017505624 A5 JP2017505624 A5 JP 2017505624A5 JP 2016549436 A JP2016549436 A JP 2016549436A JP 2016549436 A JP2016549436 A JP 2016549436A JP 2017505624 A5 JP2017505624 A5 JP 2017505624A5
Authority
JP
Japan
Prior art keywords
polypeptide
amino acid
protease
acid sequence
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016549436A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017505624A (ja
JP6718375B2 (ja
Filing date
Publication date
Priority claimed from GB201401480A external-priority patent/GB201401480D0/en
Priority claimed from GBGB1405784.8A external-priority patent/GB201405784D0/en
Application filed filed Critical
Priority claimed from PCT/GB2015/050212 external-priority patent/WO2015114343A1/en
Publication of JP2017505624A publication Critical patent/JP2017505624A/ja
Publication of JP2017505624A5 publication Critical patent/JP2017505624A5/ja
Application granted granted Critical
Publication of JP6718375B2 publication Critical patent/JP6718375B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016549436A 2014-01-29 2015-01-29 新規治療法 Active JP6718375B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1401480.7 2014-01-29
GB201401480A GB201401480D0 (en) 2014-01-29 2014-01-29 Novel treatments
GBGB1405784.8A GB201405784D0 (en) 2014-03-31 2014-03-31 Novel methods, polypeptides and uses thereof
GB1405784.8 2014-03-31
PCT/GB2015/050212 WO2015114343A1 (en) 2014-01-29 2015-01-29 Novel treatments

Publications (3)

Publication Number Publication Date
JP2017505624A JP2017505624A (ja) 2017-02-23
JP2017505624A5 true JP2017505624A5 (https=) 2018-03-08
JP6718375B2 JP6718375B2 (ja) 2020-07-08

Family

ID=52630400

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016549436A Active JP6718375B2 (ja) 2014-01-29 2015-01-29 新規治療法

Country Status (14)

Country Link
US (2) US20160339087A1 (https=)
EP (2) EP3932420A1 (https=)
JP (1) JP6718375B2 (https=)
KR (1) KR20160108560A (https=)
CN (1) CN106232810A (https=)
AU (1) AU2015212554B2 (https=)
BR (1) BR112016017478A2 (https=)
DK (1) DK3099317T3 (https=)
ES (1) ES2890555T3 (https=)
MX (1) MX384716B (https=)
PL (1) PL3099317T3 (https=)
PT (1) PT3099317T (https=)
RU (1) RU2732378C2 (https=)
WO (1) WO2015114343A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201405784D0 (en) * 2014-03-31 2014-05-14 Enzymatica Ab Novel methods, polypeptides and uses thereof
EP3120866A1 (en) * 2015-07-24 2017-01-25 Zymetech ehf. Use of marine serine proteases for removal, prevention and inhibition of formation and growth of biofilms
GB201701315D0 (en) * 2017-01-26 2017-03-15 Enzymatica Ab Novel treatments
US20210353752A1 (en) * 2018-10-11 2021-11-18 Momenta Pharmaceuticals, Inc. Treatment with highly silylated igg compositions
JP7219512B2 (ja) 2019-02-28 2023-02-08 エイチエルビー サイエンス インコーポレイテッド 抗菌活性を有するポリペプチド、これを含む敗血症の予防または治療用組成物、および抗菌用組成物
KR102368983B1 (ko) * 2019-02-28 2022-03-03 단디바이오사이언스 주식회사 항균활성을 갖는 폴리펩타이드, 이를 포함하는 패혈증 예방 또는 치료용 조성물, 및 항균용 조성물
US20230165776A1 (en) * 2020-05-13 2023-06-01 Zymiq Technology Ab Protease formulation for treatment of microbial infections

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
SE459005B (sv) 1985-07-12 1989-05-29 Aake Rikard Lindahl Saett att framstaella sfaeriska polymerpartiklar
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
JP2003502071A (ja) * 1999-06-18 2003-01-21 ブジャーナソン・ヨーン・ブラーギ 魚類セリンプロティナーゼ及びそれらの薬品及び化粧品への利用
RU2003104524A (ru) * 2000-07-13 2005-01-20 Дженс Христиан ДЖЕНСЕНИУС (DK) Masp-2, комплемент-связывающий фермент и его применение
US9511125B2 (en) * 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
WO2012104099A1 (en) * 2011-02-04 2012-08-09 Glucometrix Ag Process for the production of recombinant trypsin

Similar Documents

Publication Publication Date Title
JP2017505624A5 (https=)
NZ763123A (en) Pde9 inhibitor and use thereof
MX2022013612A (es) Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas.
GEAP201814349A (en) Indolizine derivatives as phoshoinositide 3-kinases inhibitors
MX2017007814A (es) Compuesto de carbamoilpiridona policiclicos y su uso farmaceutico.
GEP201706780B (en) Substituted 2-aza-bicyclo [2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin c
NZ709260A (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
EA038122B9 (ru) Ингибитор поверхностного антигена вируса гепатита b
WO2015183963A3 (en) Therapeutic compositions including redox-active parabenzoquinones and uses thereof
MX2019005569A (es) Nuevos derivados de quinolina.
MX2017012393A (es) Compuestos de carbamoilpiridona policiclicos y su uso farmaceutico.
MX2017004592A (es) Formulaciones farmaceuticas para la administracion oral de farmacos peptidicos o proteinicos.
NZ722927A (en) Aerosol pirfenidone and pyridone analog compounds and uses thereof
GEP201706698B (en) Inhibitors of influenza viruses replication
JP2014167010A5 (https=)
WO2016172496A8 (en) Lsd1 inhibitors and uses thereof
MX381187B (es) Nuevo derivado de quinoleina para usarse en el tratamiento y prevencion de infecciones virales.
MY193740A (en) "substituted 2,4 diamino-quinoline as new anticancer agents"
RU2016135003A (ru) Новые виды лечения
GEP20166488B (en) Co-crystals and salts of ccr3-inhibitors
BR112015025804A2 (pt) derivados de glutarimida, uso dos mesmos, composição farmacêutica com base neles e métodos para a produção de derivados de glutarimida
PH12021550901A1 (en) Pyridinyl sulfonamide derivatives, pharmaceutical compositions and uses thereof
CO7101247A2 (es) Formulaciones de ácido poliinosínico-policitidílico (poli(i:c)) para el tratamiento de infecciones de las vías respiratorias altas
MX2012008328A (es) Derivados de pirazina.
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment